Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prediction Intervals01:03

Prediction Intervals

The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
The...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three new species and a new synonym of <i>Conocybe</i> section <i>Ochromarasmius</i> subsection <i>Dumetorae</i> (<i>Bolbitiaceae</i>, <i>Agaricales</i>) from northern China.

MycoKeys·2026
Same author

Multiomic Underpinnings of Drug Targets for Intracranial Aneurysm: Evidence From Diversified Mendelian Randomization.

CNS neuroscience & therapeutics·2025
Same author

Genetically Proxied Antiplatelet Drug Target Perturbation and Risk of Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Analysis.

World neurosurgery·2025
Same author

Prediction of Human Microbe-Drug Association based on Layer Attention Graph Convolutional Network.

Current medicinal chemistry·2024
Same author

EtROP38 suppresses apoptosis of host cells infected with Eimeria tenella by inhibition of the p38MAPK pathway.

Veterinary parasitology·2024
Same author

Three-layer heterogeneous network based on the integration of CircRNA information for MiRNA-disease association prediction.

PeerJ. Computer science·2024

Related Experiment Video

Updated: Jul 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Microbe Drug Association Prediction with Bernoulli Random Forests.

Jia Qu1, Qing-Nuo Li1, Zi-Hao Song1

  • 1The School of Computer Science and Artificial Intelligence & Aliyun School of Big Data, Changzhou University, Changzhou, China.

Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|September 11, 2025
PubMed
Summary

This study introduces a new computational model, Bernoulli random forest for microbe-drug association (BRFMDA) prediction, to identify potential antibiotic treatments against drug-resistant microbes. The model demonstrates high accuracy in predicting microbe-drug associations, aiding new drug development.

Keywords:
Bernoulli random forestsassociations predictiondrugfilter-based approachmicrobe

More Related Videos

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

435

Related Experiment Videos

Last Updated: Jul 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

435

Area of Science:

  • Computational biology
  • Drug discovery
  • Microbiology

Background:

  • Rising antibiotic resistance in microbes necessitates novel therapeutic strategies.
  • Understanding microbe-drug associations is crucial for developing effective antibiotics.
  • Existing methods for predicting microbe-drug associations require enhancement.

Purpose of the Study:

  • To develop and validate a novel computational model for predicting microbe-drug associations.
  • To leverage integrated microbe and drug similarity features for enhanced prediction accuracy.
  • To provide a reliable tool for identifying potential drug candidates against resistant microbes.

Main Methods:

  • Development of a Bernoulli random forest (BRF) model for microbe-drug association prediction (BRFMDA).
  • Integration of microbe and drug similarity metrics to construct feature representations.
  • Application of filter-based feature selection and rigorous cross-validation (LOOCV, 5-fold) for performance evaluation.

Main Results:

  • BRFMDA achieved high predictive performance on both the Microbe-Drug Association Database (MDAD) and an abiofilm dataset.
  • Global LOOCV yielded an Area Under the Curve (AUC) of 0.9134 on MDAD and 0.9130 on the abiofilm dataset.
  • Cross-validation results confirm BRFMDA as a dependable model for predicting potential microbe-drug associations.

Conclusions:

  • The developed BRFMDA model offers a robust and accurate approach for predicting microbe-drug associations.
  • This computational tool can significantly accelerate the discovery of new antibiotics to combat antimicrobial resistance.
  • BRFMDA provides valuable insights for researchers in drug development and antimicrobial stewardship.